Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The International Congress of Parkinson's Disease and Movement Disorders (MDS) took place in Honolulu, HI, between October 5-9, 2025. This meeting brought together experts to discuss the latest advances in the understanding and treatment of movement disorders.

MDS 2025

International Congress of Parkinson's Disease and Movement Disorders
05–09 October 2025 | Honolulu, HI

MDS 2025

International Congress of Parkinson's Disease and Movement Disorders
05–09 October 2025 | Honolulu, HI
The International Congress of Parkinson's Disease and Movement Disorders (MDS) took place in Honolulu, HI, between October 5-9, 2025. This meeting brought together experts to discuss the latest advances in the understanding and treatment of movement disorders.
What “75% slower progression” really means in the first HTT-directed gene therapy for HD 7:20
What “75% slower progression” really means in the first HTT-directed gene therapy for HD
Alberto Espay • 1 Dec 2025
An algorithm to guide clinicians on cognitive evaluation in Parkinson’s disease 4:01
An algorithm to guide clinicians on cognitive evaluation in Parkinson’s disease
Dana Pourzinal • 20 Oct 2025
Recommendations for treating and managing cognitive disorders in Parkinson’s disease 4:34
Recommendations for treating and managing cognitive disorders in Parkinson’s disease
Dana Pourzinal • 20 Oct 2025
The prevalence of cognitive impairment in Parkinson’s disease and the need to standardize assessment 3:09
The prevalence of cognitive impairment in Parkinson’s disease and the need to standardize assessment
Dana Pourzinal • 20 Oct 2025
Basic science of movement disorders: recent updates in the field 3:17
Basic science of movement disorders: recent updates in the field
Tiago Outeiro • 15 Oct 2025
The alpha-synuclein seed amplification assay and the need to consider Parkinson’s beyond movement 2:08
The alpha-synuclein seed amplification assay and the need to consider Parkinson’s beyond movement
Tiago Outeiro • 15 Oct 2025
Key emerging data and evolving concepts in prion-like mechanisms of proteinopathies 2:42
Key emerging data and evolving concepts in prion-like mechanisms of proteinopathies
Tiago Outeiro • 15 Oct 2025
Two novel alpha-synuclein missense variants identified in patients with Parkinson’s disease 2:09
Two novel alpha-synuclein missense variants identified in patients with Parkinson’s disease
Tiago Outeiro • 15 Oct 2025
The content of VJNeurology is intended for healthcare professionals